WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation [Nasdaq: RXII], a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Tod Woolf, Ph.D., President and Chief Executive Officer, will present a corporate overview of the Company at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York City on Wednesday, November 12, 2008 at 4:30 PM ET.
